/
DCF Valuation
Base-case fair value
$27.37
Intrinsic $36.49 · 25% MOS
Current price: $262.68
Base-case summary
Our base-case DCF for BeOne Medicines Ltd. (ONC) projects 10 years of free cash flow growth at 18.4% for years 1–5 and 9.2% for years 6–10, anchored to 18.4% historical FCF growth, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $1.1B in trailing free cash flow, this produces an intrinsic value of $36.49 per share. A 25% safety margin gives a fair value of $27.37, suggesting the stock is currently 90% overvalued against the $262.68 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$1.1B
Cash & equivalents
$4.8B
Total debt
$1.2B
Shares outstanding
1.5B